 ANDOVER, Mass., Aug. 26, 2021 PRNewswire -- TransMedics Group, Inc. TransMedics Nasdaq: TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a virtual fireside chat at the upcoming Morgan Stanley 19th Annual Global Healthcare Conference. 